Overexpression of Activated Nuclear Factor‐κ B in Aorta of Patients With Coronary Atherosclerosis
Authors:
Open Access
- 21 December 2009
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 32 (12) , E42-E47
Abstract
Background Inflammation is an established risk factor for atherosclerosis. In an inflammatory state, nuclear factor-κ B (NF-κB) is frequently activated as a key transcription activator for the downstream responses. Hypothesis The aim of this study was to investigate the changes of NF-κB in the aorta of patients with coronary atherosclerosis and its association with atherosclerotic risk factors. Methods From 2004 to 2005, we collected a small piece of ascending aorta in the bypass procedure from patients (n = 31) undergoing coronary artery bypass graft (CABG) surgery. The expression of NF-κB was determined by immunohistochemistry, and its transcriptional activity was evaluated by electrophoretic mobility shift assay. Celiac aortic tissues from 4 subjects without known atherosclerosis through the kidney donation program were taken as control. Results NF-κB was detectable in aortas from CABG patients with the transcriptional activities significantly increased. The relative level of aortic NF-κB expression was elevated in patients who were smokers or with hypertension. Spearman correlation revealed that aortic NF-κB expression had significant correlation with coronary severity scores (Gensini score, r = 0.608, P < .05). The NF-κB expression was positively correlated with the levels of blood glucose, low-density lipoprotein cholesterol, lipoprotein(a), total cholesterol, and non-high-density lipoprotein cholesterol (P < .05); but negatively correlated with high-density lipoprotein cholesterol (P < .05). Conclusions Our study demonstrates a highly activated NF-κB in aortas from patients with coronary atherosclerosis, which may reflect overall arterial overinflammatory status. The findings of hyperactive NF-κB in aortas may provide a diagnostic parameter for the inflammation that is associated with and may cause atherosclerosis. CopyrightKeywords
This publication has 20 references indexed in Scilit:
- Inflammation and AtherosclerosisStroke, 2006
- The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-κB activationJournal of Thrombosis and Haemostasis, 2006
- Angiotensin II Stimulates Matrix Metalloproteinase Secretion in Human Vascular Smooth Muscle Cells via Nuclear Factor-κB and Activator Protein 1 in a Redox-Sensitive MannerJournal of Vascular Research, 2005
- Enhanced Plasma Levels of Oxidized Low-Density Lipoprotein Increase Circulating Nuclear Factor-Kappa B Activation in Patients With Unstable AnginaJACC, 2005
- Nuclear factor-κB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectorisAtherosclerosis, 2002
- Adenovirus-mediated expression of a mutant IκB kinase 2 inhibits the response of endothelial cells to inflammatory stimuliBlood, 2001
- The terminal complement complex C5b‐9 stimulates interleukin‐6 production in human smooth‐muscle cells through activation of transcription factors NF‐κB and AP‐1The FASEB Journal, 2000
- Redox Signals and NF-κB Activation in T CellsFree Radical Biology and Medicine, 1998
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- A more meaningful scoring system for determining the severity of coronary heart diseaseThe American Journal of Cardiology, 1983